Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

41.19
+2.095.35%
Pre-market: 41.280.0900+0.22%06:14 EDT
Volume:327.77K
Turnover:13.17M
Market Cap:227.78M
PE:- -
High:41.53
Open:39.32
Low:38.40
Close:39.10
52wk High:42.63
52wk Low:13.60
Shares:5.53M
Float Shares:5.53M
Volume Ratio:1.05
T/O Rate:5.93%
Dividend:17.77
Dividend Rate:43.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna appoints COO as oncology expansion accelerates

TIPRANKS
·
Sep 30

It's Inflation Day and the Stock Market is on Edge

Dow Jones
·
Sep 30

Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded it to Sell

Dow Jones
·
Sep 30

Moderna Slips After Citi Downgrades to 'sell'

Reuters
·
Sep 30

Moderna appoints Juan Andres as COO

TIPRANKS
·
Sep 30

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

TIPRANKS
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29